National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N03AX18	VIMPAT	B	Lacosamide - 10mg/ml	10mg/ml	Injectable solution	13,225,715 L.L
R03AC02	VENTOLIN	B	Salbutamol (sulfate) - 5mg/ml	5mg/ml	Solution	403,153 L.L
N03AX18	VIMPAT	B	Lacosamide - 10mg/ml	10mg/ml	Syrup	2,111,177 L.L
L01BC07	VIDAZA	B	Azacitidine - 100mg	100mg	Injectable lyophilised powder	L.L
C09DA08	VOTUM PLUS	B	Olmesartan medoxomil - 40mg, Hydrochlorothiazide - 25mg		Tablet, film coated	933,971 L.L
B05AA07	VOLUVEN	B	Starch poly(O-2-Hydroxyethyl) - 6%	6%	Injectable solution	987,724 L.L
C09DA08	VOTUM PLUS	B	Olmesartan medoxomil - 40mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	933,971 L.L
C09DA08	VOTUM PLUS	B	Olmesartan medoxomil - 20mg, Hydrochlorothiazide - 25mg		Tablet, film coated	900,374 L.L
C09DA08	VOTUM PLUS	B	Olmesartan medoxomil - 20mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	900,374 L.L
C09DB02	VOCADO	B	Olmesartan medoxomil - 20mg, Amlodipine besylate - 5mg		Tablet, film coated	971,598 L.L
S01AD09	VIRGAN	B	Ganciclovir - 1.5mg/g	1.5mg/g	Gel	804,962 L.L
C09DB02	VOCADO	B	Olmesartan medoxomil - 40mg, Amlodipine besylate - 5mg		Tablet, film coated	1,103,295 L.L
C09DB02	VOCADO	B	Olmesartan medoxomil - 40mg, Amlodipine besylate - 10mg		Tablet, film coated	1,186,613 L.L
B01AB11	VESSEL DUE F TAB.	B	Sulodexide - 250LRU	250LSU	Capsule, soft gelatin	2,792,505 L.L
L01BC07	VIDAZA	B	Azacitidine - 100mg	100mg	Injectable lyophilised powder	15,158,791 L.L
J02AC03	VFEND	B	Voriconazole - 200mg	200mg	Tablet, film coated	51,904,550 L.L
D04AB01	VERSATIS	B	Lidocaine - 5%	5%	Patch	13,085,712 L.L
M02AA15	VOLTAREN EMULGEL 12HRS	B	Diclofenac Diethylamine - 23.2mg/g	23.2mg/g	Gel	1,169,143 L.L
D04AB01	VERSATIS	B	Lidocaine - 5%	5%	Patch	2,772,347 L.L
J02AC03	V-FEND	B	Voriconazole - 200mg	200mg	Injectable powder for solution	8,078,564 L.L
M02AA15	VOLTAREN EMULGEL 12HRS	B	Diclofenac Diethylamine - 23.2mg/g	23.2mg/g	Gel	717,612 L.L
C09DX03	VOCADO HCT	B	Olmesartan medoxomil - 40mg, Amlodipine - 10mg, Hydrochlorothiazide - 25mg		Tablet, film coated	1,523,917 L.L
C09DX03	VOCADO HCT	B	Olmesartan medoxomil - 40mg, Amlodipine - 10mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	1,523,917 L.L
C09DX03	VOCADO HCT	B	Olmesartan medoxomil - 20mg, Amlodipine - 5mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	1,482,258 L.L
C09DX03	VOCADO HCT	B	Olmesartan medoxomil - 40mg, Amlodipine - 5mg, Hydrochlorothiazide - 25mg		Tablet, film coated	1,523,917 L.L
C09DX03	VOCADO HCT	B	Olmesartan medoxomil - 40mg, Amlodipine - 5mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	1,523,917 L.L
J05AB11	VALTREX	B	Valaciclovir - 500mg	500mg	Tablet, film coated	1,147,641 L.L
G03DB08	VISANNE	B	Dienogest - 2mg	2mg	Tablet	4,980,280 L.L
J05AB11	VALTREX	B	Valaciclovir - 500mg	500mg	Tablet, film coated	4,481,715 L.L
S01LA09	VABYSMO	B	Faricimab - 6mg/0.05ml	6mg/0.05ml	Injectable solution	L.L

...